Q-omics provides the consensus-scored MIR5003 profile across patient tissues and cancer cell-line models. MIR5003 expression is associated with patient survival in 8 of 34 cancer types, with the highest sampling consensus in SKCM. Additionally, MIR5003 RNA expression shows 7,360 significant protein co-abundance associations, with the highest sampling consensus in HNSC. Together, these results highlight SKCM, and HNSC as cancer lineages where MIR5003 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.